Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...

The global CRISPR-based gene editing market size is projected to grow from USD 4.46 billion in 2025 to over USD 13.39 billion by 2034, expanding at a CAGR of 13%. Growth is fueled by advancements in ...

The global CRISPR-based gene editing market size was estimated to be USD 4.14 billion in 2023 and is expected to reach USD 18.84 billion by 2034 with a CAGR of 14.76% during the forecast period ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

Researchers used evolutionary genetics and CRISPR gene editing tech to develop an innovative treatment for gout. The approach ...

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

CRISPR Therapeutics CRSP and Beam Therapeutics BEAM are leading developers of therapies that utilize the Nobel Prize-winning ...

A powerful new gene-editing technology called CRISPR has enormous potential to treat human diseases but the ability to tinker with genes can also be controversial. Here we explain what CRISPR is ...

Gout – a form of arthritis caused by the build-up of uric acid crystals in joints – is one of humanity’s oldest known diseases. Now, scientists at Georgia State University, Atlanta, have ...

Patients are about to be enrolled in the first study to test a gene-editing technique known as CRISPR inside the body to try to cure an inherited form of blindness.

Television CRISPR: Coroner tackles the ethics of gene editing Coroner has explored everything from psychology to murder, love and now something completely unexpected.